Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1520Carcinoma, Non-Small-Cell Lung 754Breast Neoplasms 572Neoplasm Metastasis 529Colorectal Neoplasms 445Melanoma 391Leukemia, Myeloid, Acute 371Multiple Myeloma 363Ovarian Neoplasms 352Recurrence 336Lymphoma 334Advanced Solid Tumors 324Lymphoma, Non-Hodgkin 314Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 232Carcinoma, Renal Cell 225Squamous Cell Carcinoma of Head and Neck 210Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 183Solid Tumors 182Carcinoma, Hepatocellular 164Hematologic Neoplasms 155Head and Neck Neoplasms 152Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

veliparib 1Radiation 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Locally Advanced Rectal Cancer × Clear all
NCT01589419 2017-11-20

A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

AbbVie

Phase 1 Completed
32 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡